CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Cholesterol Lowering Drug

esperion

Esperion Announces Positive Phase 2 Clinical Trial Results for ETC-1002

Esperion Therapeutics, a privately held biotechnology company in Plymouth, Monday announced positive results from a Phase 2 clinical trial for its potential cholesterol buster, ETC-1002.

WWJ Newsradio 950–03/26/2012

Follow

Get every new post delivered to your Inbox.

Join 1,870 other followers